Headline News about Sanofi-Aventis S.A. ADR![]() ![]()
Earnings Outlook For Sanofi
February 02, 2023
Via Benzinga
![]() Via Benzinga
![]() ![]() ![]()
Hopeful Golden Cross Forms On Sanofi's Chart
January 26, 2023
Via Benzinga
![]() ![]() Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Regeneron-Sanofi's Dupixent Wins European Approval For Prurigo Nodularis
December 15, 2022
Via Benzinga
![]() ![]() ![]() Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|